Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Concerns regarding Transfusions of Blood Products Derived from Genetic Vaccine Recipients and Proposals for Specific Measures

Jun Ueda
* ORCID logo ,
Hideyuki Motohashi
,
Yuriko Hirai
,
Kenji Yamamoto
ORCID logo ,
Yasufumi Murakami
,
Masanori Fukushima
,
Akinori Fujisawa
* ORCID logo
Version 1 : Received: 14 March 2024 / Approved: 15 March 2024 / Online: 15 March 2024 (08:54:06 CET)

How to cite: Ueda, J.; Motohashi, H.; Hirai, Y.; Yamamoto, K.; Murakami, Y.; Fukushima, M.; Fujisawa, A. Concerns regarding Transfusions of Blood Products Derived from Genetic Vaccine Recipients and Proposals for Specific Measures. Preprints 2024, 2024030881. https://doi.org/10.20944/preprints202403.0881.v1 Ueda, J.; Motohashi, H.; Hirai, Y.; Yamamoto, K.; Murakami, Y.; Fukushima, M.; Fujisawa, A. Concerns regarding Transfusions of Blood Products Derived from Genetic Vaccine Recipients and Proposals for Specific Measures. Preprints 2024, 2024030881. https://doi.org/10.20944/preprints202403.0881.v1

Abstract

The coronavirus pandemic was declared by the World Health Organization (WHO) in 2020, and a global genetic vaccination program has been rapidly implemented as a fundamental solution. However, many countries around the world have reported that so-called genetic vaccines, such as those using modified mRNA encoding the spike protein and lipid nanoparticles as the drug delivery system, have resulted in post-vaccination thrombosis and subsequent cardiovascular damage, as well as a wide variety of diseases involving all organs and systems, including the nervous system. In this article, based on these circumstances and the volume of evidence that has recently come to light, we call the attention of medical professionals to the various risks associated with blood transfusions using blood products derived from people who have suffered from long COVID and from genetic vaccine recipients, including those who have received mRNA vaccines, and we make proposals regarding specific tests, testing methods, and regulations to deal with these risks. We expect that this proposal will serve as a basis for discussion on how to address post-vaccination syndrome and its consequences following these genetic vaccination programs.

Keywords

COVID-19 vaccine; genetic vaccine; blood product; blood transfusion; spike protein; post-vaccination syndrome; harm–benefit assessment; prion; spikeopathy; inspection standard; diagnostic criteria

Subject

Medicine and Pharmacology, Transplantation

Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Download PDF

Comments (1)

Comment 1
Received: 18 March 2024
Commenter:
Geoff Pain

The commenter has declared there is no conflict of interests.
Comment: The authors have too narrow a focus on mRNA Spike Protein antigen as a hazard in transfused Blood and Blood Products.
Numerous "Spikeopathy" studies are fatally flawed because commercial Spike Protein batches were contaminated with Endotoxin.
https://geoffpain.substack.com/p/gmo-spike-protein-carries-e-coli I have gathered evidence, with a number of studies listed, that Endotoxin in Covid19 jabs is a major factor in IgG4 contamination of Blood and Blood Products.
https://geoffpain.substack.com/p/igg4-affected-by-endotoxin-in-mrna and
https://geoffpain.substack.com/p/red-cross-australia-refuses-to-protect I encourage the authors to expand their cited literature to include some of the references I provide.
+ Respond to this comment

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 1
Metrics 0
Get PDF Cite Share 1
Bookmark BibSonomy Mendeley Reddit Delicious
×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.